01 June 2020
Visiongain has launched a new report Constipation Nutraceuticals Market Report 2020-2030: Forecasts by Segment (Fibers & Specialty Carbohydrates, Vitamins, Minerals, Carotenoids, Omega-3 Fatty Acids, Prebiotics & Probiotics, Amino Acids & Proteins, Others); by Form (Dry Form and Liquid Form). Plus Financial Analysis of Leading Companies and Regional and Leading National Market Analysis.
Visiongain has forecasted that the global constipation nutraceuticals market will see a revenue of $xyz billion in 2020. Nutraceuticals are the products that provide medicinal and health benefits to the people. These products provide additional nutritional value to the foodstuff. Since 1990’s, there has been a considerable shift in the preference among the consumers towards consumption of nutraceuticals. Presently, the population segment prefers consumption of nutraceuticals as they help to reduce the expensive and high-tech disease treatment. Constipation Nutraceuticals are primarily used in dietary supplements, functional food and beverages as they have natural properties that are essential for disease prevention, and health promotion. Currently, majority of the population segment are aware about their health and believe that proper intake of nutrition can prevent the occurrence of chronic diseases. Nutraceuticals are not only consumed to maintain the dietary allowance but to enhance the performance and prevent diseases. Thus, nutraceuticals as a term is referred to food and food products that after consumption can provide incremental health benefits.
To access the data contained in this document please email firstname.lastname@example.org
The global constipation nutraceuticals market is rising majorly due to increasing geriatric population, rising prevalence of chronic diseases, growing obese population and increasing health awareness. However, high cost of the products and availability of the products are some of the factors that might restrict the growth of the market to some extent during the study period.
On the basis of segment, fibers & specialty carbohydrates segment dominated the global constipation nutraceuticals market in 2020. The dominance of this market segment was majorly due to increasing preference among the population for healthy and nutritional food. Prebiotics and probiotics market segment is estimated to be the most lucrative market during the forecast period from 2020-2030. The growth in this market segment was majorly due to advantages of these products on gut health and increasing application areas, collectively all these factors support the future growth of the prebiotics and probiotics market segment during the study period.
On the basis of form, the dry form segment is expected to dominated the global constipation nutraceuticals market. The dominance of this market segment was majorly due to preference among the companies for this form as its helps to maintain the moisture and nutrient value in the products. In addition, it also retains the shelf life of the product.
Geographically, Asia-Pacific region accounted for the largest market share owing to rising demand for healthy and nutritional products, increasing awareness, rising disposable income and changing lifestyle. In addition, increasing population base and rising demand also support the growth of the regional market during the forecast period.
• DuPont de Nemours, Inc.
• Glanbia Plc
• Associated British Foods, Plc
• Ingredion Incorporated
• Tate & Lyle
• Ajinomoto Group
• BASF SE
• Kerry Group
• Cargill, Inc.
• Arla Foods
• Chr. Hansen Holding A/S
Visiongain's global constipation nutraceuticals market report can keep you informed and up to date with the developments in the market, across four different regions: North America, Europe, Asia-Pacific, South America and Middle-East & Africa.
With reference to this report, it details the key investments trend in the global market, subdivided by segment, by form and by regions. Through extensive secondary research and interviews with industry experts, Visiongain has identified a series of market trends that will impact the constipation nutraceuticals market over the forecast timeframe.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.
21 June 2022
The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.
20 June 2022
The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.
15 June 2022
The global artificial intelligence (AI) in drug discovery market was valued at US$791 million in 2021 and is projected to grow at a CAGR of 30.7% during the forecast period 2022-2032.